Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    China Life Sciences: 2024 Year In Review

    The life sciences industry remained a primary focus for Chinese regulators in 2024. Key developments such as China's first draft law regulating the medical device industry, the Medical Device Administration Law (《中华人民共和国医疗器械管理法(草案征求意见稿)》),
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    《RDPAC数字医疗合规指南》简析(公司内控合规系列)

    互联网、大数据、人工智能等数字技术的创新应用,正快速改变传统医疗服务模式。而数字医疗除了受到传统医疗的法律规制,其数字化的特
    ChinaFood, Drugs, Healthcare, Life Sciences
    AnJie Broad Law Firm
    AnJie Broad Law Firm
Article

Hankun • Quick Comment | The Regulations On Human Genetic Resources Management Are Revised Again

On March 15, the website of the Central People's Government released State Order No. 777 "Decision of the State Council on Amending and Abolishing Certain Administrative Regulations" ("Decision")...
ChinaFood, Drugs, Healthcare, Life Sciences
Han Kun Law Offices
Han Kun Law Offices
  • Article

    2023年度の国家医療機器政策

    2023年 4月 26日、インド政府 (GOI)は 「 国家医療機器政策 2023」を承 認 し ました。
    ChinaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    汉坤 • 观点 | 简评新版《医疗器械临床试验质量管理规范(GCP)》

    自国务院于2015年发布《关于改革药品医疗器械审评审批制度的意见》(国发〔2015〕44号)并启动药品医疗器械审评审批制度改革工作以来,我国不断߾
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    China On The Move: Key Takeaways From The 2025 NRDL Negotiations And Adjustment

    China's role in the global pharmaceutical innovation market is undergoing a substantial shift.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    药企出海新热点:管线分拆"SON"模式的实践解读

    近期,医药行业正掀起一股"管线分拆项目"("Spin off-NewCo",或称"SON"模式)的热潮。短短两个月,笔者即接手了近十起管线分拆项目。
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    面对肺炎疫情,海外机构如何对华开展物资援助?

    随着新型冠状病毒肺炎疫情(以下简称"肺炎疫情")...
    ChinaFood, Drugs, Healthcare, Life Sciences
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    The Regulatory Data Protection Regime In China (Draft For Comments)

    The National Medical Products Administration (NMPA) issued the Implementation Measures for Drug Regulatory Data Protection and the Drug Regulatory Data Protection Working Procedures on March 19, 2025.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Fangda Partners
    Fangda Partners
  • Article

    被传染新冠肺炎能否向传播者索赔?

    2019年12月以来,湖北省武汉市陆续发现新型冠状病毒肺炎...
    ChinaLitigation, Mediation & Arbitration
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    新冠肺炎疫情下政府应急征用的若干法律问题

    随着新型冠状病毒肺炎(以下简称"新冠肺炎")...
    ChinaGovernment, Public Sector
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    What Companies Need To Know About China's New Market Regulator

    On March 17, China's highest legislative body, the National People's Congress, approved a sweeping government restructuring plan.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    Han Kun • Opinion | Interpretation Of The "Detailed Rules For The Supervision Of Internet Diagnosis And Treatment (Trial)"

    Since the General Office of the State Council issued the "Opinions on Promoting the Development of "Internet + Medical Health" on April 25...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    医药健康企业融资谈判过程中需要创始人注意的两三事(上篇)

    近两年,因为生物医药类企业IPO承压...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Jincheng Tongda & Neal
    Jincheng Tongda & Neal
  • Article

    Han Kun • Opinion | Hainan Boao Lecheng Clinical Urgently Needs A Review Of The Highlights Of The New Regulations On The Management Of Imported Drugs And Devices

    On March 28, 2023, the Hainan Provincial People's Government officially issued the "Regulations on the Administration of Imported Drugs and Medical Devices Urgently Needed in Clinical Needs...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    汉坤 • 观点 | 细胞与基因治疗领域又一利好:研究者发起的临床研究(IIT)管理办法正式落地

    近日,国家卫生健康委员会(下称"国家卫健委")、国家中医药局和国家疾控局三部委联合发布了...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    医疗健康数据的法律保护与合规应用

    数据资源作为重要生产要素蕴藏了巨大的价值,被认为是面向未来的数字经济"石油",其中,医疗健康行业的数据公认具有较大的开发潜力。
    ChinaFood, Drugs, Healthcare, Life Sciences
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    Protected: China | Data Exclusivity Comes Into Effect

    China's National Medical Products Administration has introduced new Implementation Measures for the Protection of Drug Trial Data, establishing a dual-track system of patent and data protection for pharmaceuticals. The measures grant data exclusivity periods ranging from 3 to 6 years for innovative drugs, improved new drugs, and generic drugs, with significant changes from earlier drafts including removal of time-gap reductions and extended protection for improved formulations.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Spruson & Ferguson Lawyers
    Spruson & Ferguson Lawyers
  • Article

    自我居家隔离?强制隔离?抗疫不听劝,隔离得服法!——浅谈自我居家隔离和强制法律性质及依据

    距离1月20日国家卫健委将新型冠状病毒...
    ChinaFood, Drugs, Healthcare, Life Sciences
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    创新医疗器械审批程序简介及知识产权相关问题探讨

    当前,我国医疗器械行业已经进入了快速发展期,数据显示,2017年至2022年,中国医疗器械行业市场规模不断增加,从4403亿元增长至9573亿元,2023年预计
    ChinaIntellectual Property
    CCPIT Patent and Trademark Law Office
    CCPIT Patent and Trademark Law Office
  • Showing 181–200 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics